Corcept Therapeutics (CORT) Retained Earnings (2010 - 2026)

Corcept Therapeutics (CORT) has 17 years of Retained Earnings data on file, last reported at $918000.0 in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 99.84% year-over-year to $918000.0; the trailing twelve-month figure through Mar 2026 stood at $918000.0 (down 99.84% YoY), and the FY2025 full-year result was $2.3 million, down 99.58% from the prior year.
• Retained Earnings slipped to $918000.0 in Q1 2026, from $2.3 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $662.3 million in Q4 2022 to a low of -$2.4 million in Q3 2022.
• A 5-year average of $273.4 million and a median of $339.8 million in 2023 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings slumped 101.46% in 2022 and surged 281333.99% in 2024, its largest moves.
• Tracing CORT's Retained Earnings over 5 years: stood at $662.3 million in 2022, then slumped by 39.23% to $402.5 million in 2023, then soared by 35.08% to $543.7 million in 2024, then plunged by 99.58% to $2.3 million in 2025, then tumbled by 59.45% to $918000.0 in 2026.
• Business Quant data shows CORT's Retained Earnings at $918000.0 in Q1 2026, $2.3 million in Q4 2025, and $619.1 million in Q3 2025.